Table 1 Baseline demographics of entire population stratified by the level of FHR
Baseline characteristics | Fibrinogen to HDL-cholesterol ratio | |||||
|---|---|---|---|---|---|---|
Overall | Q1 (< 3.11) | Q2 (3.11–4.50) | Q3 (4.50–6.35) | Q4 (> 6.35) | P-value | |
N = 13,221 | N = 3306 | N = 3305 | N = 3305 | N = 3305 |  | |
Demographic characteristics | ||||||
 Age (years) | 61.7 ± 12.0 | 62.9 ± 12.4 | 61.7 ± 12.2 | 61.5 ± 11.6 | 60.5 ± 11.7 |  < 0.001 |
 Female | 2393 (18.1) | 739 (22.4) | 661 (20.0) | 603 (18.2) | 390 (11.8) |  < 0.001 |
 Smoke | 4970 (46.9) | 1116 (43.8) | 1200 (46.0) | 1262 (46.9) | 1392 (50.5) |  < 0.001 |
Medical history and clinical condition | ||||||
 CHF | 4545 (34.4) | 1055 (31.9) | 1073 (32.5) | 1102 (33.3) | 1315 (39.8) |  < 0.001 |
 CKD | 2969 (22.5) | 589 (17.8) | 650 (19.7) | 814 (24.6) | 916 (27.7) |  < 0.001 |
 DM | 4307 (32.6) | 761 (23.0) | 1002 (30.3) | 1206 (36.5) | 1338 (40.5) |  < 0.001 |
 AF | 532 (4.0) | 180 (5.4) | 114 (3.4) | 122 (3.7) | 116 (3.5) |  < 0.001 |
 Hypertension | 6212 (47.0) | 1405 (42.5) | 1537 (46.5) | 1623 (49.1) | 1647 (49.8) |  < 0.001 |
 Hyperlipemia | 9926 (75.1) | 1912 (57.8) | 2228 (67.4) | 2650 (80.2) | 3136 (94.9) |  < 0.001 |
 Anemia | 469 (3.5) | 143 (4.3) | 101 (3.1) | 111 (3.4) | 114 (3.4) | 0.035 |
 Stroke | 745 (5.6) | 158 (4.8) | 190 (5.7) | 183 (5.5) | 214 (6.5) | 0.028 |
 PCI | 11,712 (88.6) | 2803 (84.8) | 2904 (87.9) | 2966 (89.7) | 3039 (92.0) |  < 0.001 |
Laboratory tests | ||||||
 Fibrinogen (g/L) | 4.5 ± 1.6 | 2.9 ± 0.7 | 3.9 ± 0.8 | 4.9 ± 0.9 | 6.4 ± 1.3 |  < 0.001 |
 APOA (g/L) | 1.1 ± 0.3 | 1.3 ± 0.3 | 1.1 ± 0.2 | 1.0 ± 0.2 | 0.9 ± 0.2 |  < 0.001 |
 APOB (g/L) | 0.9 ± 0.3 | 1.0 ± 0.4 | 1.0 ± 0.3 | 0.9 ± 0.3 | 0.9 ± 0.2 |  < 0.001 |
 TC (mmol/L) | 4.7 ± 1.3 | 5.2 ± 1.3 | 4.8 ± 1.3 | 4.6 ± 1.2 | 4.2 ± 1.1 |  < 0.001 |
 TG (mmol/L) | 1.6 ± 1.2 | 1.5 ± 1.3 | 1.7 ± 1.2 | 1.7 ± 1.0 | 1.6 ± 1.0 |  < 0.001 |
 LDL-C (mmol/L) | 3.1 ± 1.1 | 3.5 ± 1.2 | 3.2 ± 1.1 | 3.0 ± 1.0 | 2.8 ± 0.9 |  < 0.001 |
 HDL-C (mmol/L) | 1.0 ± 0.3 | 1.3 ± 0.3 | 1.0 ± 0.2 | 0.9 ± 0.2 | 0.8 ± 0.2 |  < 0.001 |
 Hemoglobin (g/L) | 132.9 ± 18.3 | 136.4 ± 17.4 | 135.0 ± 17.9 | 132.1 ± 18.5 | 128.3 ± 18.3 |  < 0.001 |
 Monocyte (10^9/L) | 0.8 ± 0.4 | 0.7 ± 0.3 | 0.7 ± 0.4 | 0.8 ± 0.3 | 0.8 ± 0.4 |  < 0.001 |
 SCr (umol/L) | 1.1 ± 0.8 | 1.0 ± 0.5 | 1.1 ± 0.8 | 1.1 ± 0.8 | 1.3 ± 1.0 |  < 0.001 |
 CKMB (U/L) | 71.9 ± 171.5 | 149.1 ± 271.0 | 80.0 ± 155.2 | 37.1 ± 84.7 | 21.7 ± 57.1 |  < 0.001 |
 WBC (10^9/L) | 11.2 ± 83.1 | 12.3 ± 86.6 | 10.3 ± 14.4 | 12.3 ± 140.5 | 9.8 ± 11.5 | 0.489 |
 PLT (10^9/L) | 241.8 ± 80.3 | 225.2 ± 67.5 | 234.4 ± 73.8 | 244.2 ± 79.1 | 263.3 ± 93.5 |  < 0.001 |
 ALB (g/L) | 36.3 ± 5.2 | 39.6 ± 4.8 | 37.4 ± 4.6 | 35.4 ± 4.3 | 32.8 ± 4.6 |  < 0.001 |
Medication during hospitalization | ||||||
 CCB | 1167 (9.3) | 230 (7.7) | 296 (9.5) | 333 (10.4) | 308 (9.6) | 0.003 |
 Statins | 11,959 (95.7) | 2857 (96.2) | 2989 (95.7) | 3036 (95.0) | 3077 (95.8) | 0.097 |
 β-blockers | 10,064 (80.5) | 2210 (74.4) | 2533 (81.1) | 2646 (82.8) | 2675 (83.3) |  < 0.001 |
 ACEI/ARB | 8553 (68.4) | 1810 (61.0) | 2173 (69.6) | 2288 (71.6) | 2282 (71.1) |  < 0.001 |
 Antiplatelets | 12,365 (98.9) | 2926 (98.6) | 3087 (98.9) | 3160 (98.8) | 3192 (99.4) | 0.011 |